drugset / Trial / NCT00625547
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of cabergoline compared with levodopa in the treatment of patients with RLS.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabergoline | Small molecule | 2 mg | Oral |
| Subject | Levodopa | Small molecule | 100 mg | Oral |